Allergy is common and the prevalence has increased substantially in the last 2-3 decades. There has been a particular increase in severe allergic disease, including anaphylaxis, food, drug and latex rubber allergy. Provision of allergy services in the NHS is extremely poor and there is a huge unmet need. Allergy is a full speciality, but there are few consultants and few trainees. Whilst other specialists have a role in the management of allergy, it is no longer adequate to devolve most of allergy care to them. Provision of allergy care must be lead by allergy specialists so that adequate standards of care can be achieved. The lack of care leads to morbidity, mortality and substantial cost to the NHS, much of which is avoidable. There is an urgent need for the creation of more consultant posts in allergy and this requires recognition by Trust Managers, Regional Commissioners and the Department of Health.
Appropriate referral
Angioedema is an example of a disorder where the appropriate referral pathway is not clearly defined. Angioedema is often associated with urticaria, and the latter (particularly idiopathic urticaria) was traditionally the province of the dermatologist. However, allergy is increasingly a cause of angioedema/urticaria, particularly the more severe forms and general dermatologists do not have the training to determine allergic aetiology or advise on management (note: this is distinct from contact dermatitis, a Tcell-mediated reaction, where patch testing is the diagnostic test and which is the province of dermatologists). Angioedema is often severe, e.g. glottal oedema which may lead to asphyxia and respiratory arrest or facial and laryngeal oedema: problems commonly due to allergy. Referral to ENT or respiratory medicine is also not appropriate. Aspirin, NSAID or ACE-induced angioedema are examples of non-IgE mediated reactions which should be referred to an allergist and where determination of aetiology is essential.
Most asthmatics can be dealt with in primary care or by respiratory physicians. However, the allergic aetiology is often not addressed (although some asthma nurses in general practice are beginning to receive allergy training through the National Asthma and Respiratory Training Centre). Referral to an allergist is appropriate for a proportion of patients with asthma, particularly those with asthma as part of multisystem allergic disease, poorly controlled asthma or severe asthma where an allergic aetiology might be suspected, and in patients with acute life-threatening attacks. The identification of allergic triggers may be important and their avoidance a key part of management. There are examples of fatal anaphylaxis which have been mislabelled as asthma deaths. Asthma was a key part of the syndrome but there had been failure to recognise the allergic aetiology both in life and in the terminal event. Involvement of an allergist in such patients should lead to accurate diagnosis, better management and reduce morbidity and mortality. However, even in more ordinary asthma, allergen avoidance (e.g. house dust mite) is often an important part of management and can improve control and/or reduce the need for medication.
The majority of patients with hayfever can be controlled with straight forward medication (oral antihistamines and/or nasal steroids and/or chromoglycate eye drops) and can be dealt with in general practice. However patients with severe hayfever not readily controlled by standard medical treatment should be referred for an allergy opinion. An allergist can usually control the disease either by providing medical treatment under expert direction or by offering desensitisation (immunotherapy). A patient referred to us recently illustrates the consequences of failure to refer appropriately. This man had devastating hayfever symptoms with profuse and uncontrolled nasal discharge. His general practitioner resorted to annual injections of a deposteroid over 14 years. This led to bilateral avascular necrosis of the hip, with the result that a 39-year-old is crippled and faces (in the long term, multiple) bilateral hip replacements 1 .
Epidemiology
This will not be described in detail as it is dealt with elsewhere in this issue. It is important to emphasise two key factors: the increase in common allergic disease and the increase in severe allergic disease. It is well known that the prevalence of asthma, rhinitis and eczema have doubled or trebled in the last 2-3 decades 2 ' 3 . Much of this is due to the increase in the allergic component of these diseases. The ISAAC study shows the world-wide increase in allergic disease in children 4 . Following this upsurge in atopy and common allergic disorders, there has been an increase in severe allergic disorders. This is less well documented but clear to those in clinical practice. Peanut and tree nut allergy has become common in the UK since the early 1990s. One study showed the incidence of confirmed peanut allergy was 1 in 200 4-year-olds 5 . A telephone questionnaire study in the US found an incidence of peanut at Pennsylvania State University on February 26, 2014 http://bmb.oxfordjournals.org/ Downloaded from allergy of about 1% (most of the respondents were adults): even allowing for the errors intrinsic in self-diagnosis, peanut allergy is evidently common. Anaphylaxis has become more common and is now a major part of referrals to an allergist (see below). There is lack of previous prevalence data. A study carried out in 1993/94 looking at anaphylaxis occurring in the community (i.e. excluding hospital-induced anaphylaxis) found this occurred in 1 in 300,000 of the population each year 6 . Because of the design of this study the authors felt it underestimated the true incidence. Hospital admissions due to anaphylaxis have also risen 7 . Since most patients with anaphylaxis are not admitted from accident and emergency departments, again the extent of the problem is underestimated.
Adverse reactions to drugs seem to be more common, e.g. due to aspirin, non-steroidal anti-inflammatory drugs, other analgesics and ACE inhibitors, often presenting with severe reactions such as glottal oedema, laryngeal oedema, severe asthma or severe generalised urticaria and angioedema.
Adverse reactions during anaesthesia, presenting with anaphylaxis, are usually due to allergy to the induction agents used in general anaesthesia. The incidence is reported as 1 in 3500 to 1 in 6000 in France 8 , and 1 in 10,000 to 1 in 20,000 in Australia 9 . Extrapolating from these figures, one would expect 175-1000 reactions in the UK each year.
Latex rubber allergy is a relatively new disease, particularly of the last decade. The first case was reported in 1919 and the second case in 1979, but since then large numbers have occurred particularly amongst those exposed to latex rubber, mainly from surgical or other rubber gloves. The main groups affected are health care workers -including doctors, nurses, paramedics and dentists -laboratory staff and patients having multiple surgical procedures 10 -11 . The larger studies of hospital staff focus on sensitisation (the presence of latex rubber IgE) rather than clinical allergy and the incidence varies from ~3-17%. 12 - 13 About half of those sensitised have clinical allergy.
Oral allergy syndrome is a relatively new problem on which there is little prevalence data but which appears to be coming much more common. In this disorder, patients are allergic to fresh fruits and vegetables which cause oedema and pruritus of the oral mucosa, sometimes also involving the pharynx and larynx. This disorder is associated with tree pollen allergy and certain types of nut allergy and usually occurs in atopies. The incidence is not known.
The European White Paper on allergy highlights the problem of the impact of allergy across Europe.
Expertise required by an allergist
The knowledge required by an allergist falls into two main areas: (i) that which is unique to allergy; and (ii) expertise in organ-based specialties, covering only part of these specialties but relevant to the problems encountered in allergy.
Specialist knowledge
This includes (Table 2) understanding of:(i) the immunological principles and pathogenesis of allergic disease; (ii) knowledge of allergens; and (iii) the aetiology of disorders (whether they are allergic or non-allergic). They also have expertise in the clinical presentation and patterns of allergic disease, the use and interpretation of diagnostic tests (an area poorly understood by the medical profession leading to confusion and bad management), and the management of allergic disease.
Knowledge overlapping with organ-based specialists
The allergist must have detailed knowledge of aspects of respiratory medicine, dermatology and ENT (Table 2) . However, good knowledge of other areas of medicine is also necessary, particularly gastroenterology (including knowing when to refer) and general (internal) medicine. Paediatrics is another important area of overlap. Whilst the ideal would be for a child to be seen by a paediatric allergist or a paediatrician with an interest in allergy, this is unrealistic at present. There are few paediatric allergists nationally and no formal training programme in paediatric allergy, so there is lack of expertise amongst paediatricians. Allergy is common in children and it is better for a child to be seen by a specialist allergist rather than a paediatrician without appropriate knowledge. It is, therefore, essential for allergists to incorporate paediatric practice into their clinics: (i) awareness of the differences between paediatric and adult practice; (ii) understanding the natural history of disease in children; (iii) knowledge of therapy and doses for children; (iv) providing an appropriate environment including play areas, activities, and having nurses and doctors appropriately dressed in clinics; and (v) handling families sensitively. Adult allergists must liaise with paediatric colleagues so there is ready access to consultation and joint care when required. Close liaison with the community paediatric team is also important for the management of children at risk of anaphylaxis in schools 14 .
Demand for allergy services

The need in the community
There is a large unmet need, evident from a number of sources.
Help lines
Two charities, the Anaphylaxis Campaign and the British Allergy Foundation, have set up help lines for the public. They are inundated with calls, the commonest problem being the difficulty patients have in obtaining allergy advice. The British Society for Allergy and Clinic Immunology have published a handbook of allergy clinics in the UK and this has been sent to all general practices. 
Lack of allergy expertise
The difficulty in obtaining allergy advice is illustrated in Figure 1 (prepared by Hazel Gowland for the Anaphylaxis Campaign).
Deaths
Deaths from anaphylaxis occur, mainly in otherwise healthy teenagers or young adults, which should be preventable. Most of these patients knew of their allergy, e.g. a food allergy, but had not been referred to an allergist or received expert advice.
Morbidity
Failure to diagnose and treat allergy leads to enormous morbidity (Tables 3 & 4) .
Demand: the experience of an allergy clinic
There is a steady and substantial rise in referrals to specialist allergy centres. The Allergy Clinic in Cambridge serves the Eastern Region (population 5.4 million), yet has a single consultant allergist. Activity for the past 5 years ( Figure 2 ) shows an increase of 440%. This figure underestimates the true increase in work-load, since over the same period there has been a change in case-mix to the more complex. This is reflected in part by the increase in day case activity which includes patients attending for challenge tests (most commonly to drugs or foods, where challenge may be the only way to confirm or refute the cause of a severe reaction).
Despite this increase in activity, the waiting list continued to rise and was 16 months in 1998. Referrals to this clinic are triaged on the basis of the referral letter into 'urgent', 'soon' or 'routine'. Urgent and soon patients are given priority and receive appointments but routine patients wait for over 12 months before they are allocated an appointment date. The number of referrals continues to exceed the capacity for new patients, activity exceeds contract levels by about 50% and activity was 20% more in 2000 compared to 1999, and 26% more in 1999 compared to 1998. 
Value of a specialist allergy service
Control of disease: cost savings to the NHS
A specialist allergy service will be able to deal with the disorders and problems in Table 3 . Identification of aetiology prevents or reduces the risk of repeated severe reactions, e.g. anaphylaxis or angioedema. In addition, management, including written treatment plans which the patient carries, are invaluable for dealing with future reactions, should these occur. In many areas of allergy, prevention with a system for immediate treatment, means reduced morbidity and substantial cost savings to the National Health Service. A recent study reported such cost-benefit. A management strategy for nut allergy was developed and then evaluated in 567 patients over 13,610 patient-months 15 . It showed not only a substantial reduction in the incidence of follow-up reactions, but where reactions did occur they were mostly mild. This demonstrated the value of repeated advice on avoidance. Patients also carried medication for self-administration {e.g. an adrenaline auto-injector) and this was effective or appropriate in all but one patient. Hospital admission and A&E attendance was avoided.
Identification of aetiology can also lead to better control of chronic diseases, such as asthma, rhinitis and eczema, through allergen avoidance, e.g. house dust mite, cat or a food 16 -17 . Knowledge of the allergic trigger also identifies the time when symptoms will begin, e.g. in seasonal allergies such as spring hayfever (tree pollen allergy) or severe late summer asthma (allergy to alternaria) or intermittent exposure to an animal, through a planned visit to a relative. Prophylactic treatment can be instituted when symptoms are expected.
Identification of what is safe
If a food or drug is suspected of causing anaphylaxis or an allergic reaction, there is great concern amongst patients and doctors as to what can be safely given. This applies to reactions occurring during general anaesthesia, after local anaesthetic, analgesics or antibiotics and in putative food allergy. An allergist can not only identify the cause, but importantly, also identify which drugs can be safely given. Until the cause of anaphylaxis during general anaesthesia is established, it is likely that all drugs given at induction will be avoided and this may increase the risk of future anaesthesia. Similarly, in putative local anaesthetic allergy, dentists refuse to administer local anaesthetic. The role of the allergist is to confirm, or more often refute, this sensitivity. This usually involves a challenge test in a centre with expertise and the appropriate facilities.
A patient referred with anaphylaxis was known to have morphine allergy, but after a series of day-case challenge tests we found she was also sensitive to all of the potent analgesics tested. During the period of investigation she had an emergency appendicectomy and spinal anaesthesia had to be used for pain relief. This type of patient required urgent referral to a specialist allergy clinic -this type of service is not available in large parts of England.
Cost benefit
Training
Allergy services are largely outpatient based and involve few investigations (skin prick tests are the main investigation). They are, therefore, relatively cheap. There are substantial cost savings to the Health Service as a result of employing specialist allergists (Tables 3 & 4) .
Allergy has suffered a period of difficulty because of the Caiman changes. Previously, the training scheme for allergy was within the Clinical Immunology and Allergy training programme. The curriculum was provided by the Royal College of Physicians speciality committee in Clinical Immunology and Allergy and training regulated by the Joint Committee on Higher Medical Training (JCHMT). All entrants to this scheme were senior registrars.
When the Caiman changes in training were introduced, a new programme was written, with entry at specialist registrar level. Up to this time, immunology (immunopathology) training had been regulated by the Royal College of Pathologists and not the JCHMT, the key requirement being the MRCPath examination. A Working Party, then Joint Committee, was set up between the Royal College of Physicians and the Royal College of Pathologists to look at areas of overlap between physicians and pathologists dealing with immunological problems. A joint training scheme was considered but abandoned, a fundamental difference being the requirement of the Royal College of Pathologists training scheme, for the MRCPath examination and training to run a diagnostic laboratory service. Two separate Caiman training programmes therefore emerged, Allergy and Immunology. Allergy was not on the initial specialist list so this programme was not formally recognised until the second specialist list was accepted by the Specialist Training Authority in 1999.
Throughout this period of uncertainty the number of trainees in post fell (from 13 whole time equivalents on the Clinical Immunology and Allergy programme to 4 on the new Allergy programme). Manpower training positions in allergy were lost, and numbers are now at an all time low. This is despite the fact that allergic disease is common, there is a great need for more specialists and there is geographical inequality of provision of care, most specialist allergists being in London or the south-east of England.
It is important to recognise that Immunology and Allergy are not the same. Allergy services in hospitals should be provided primarily by trained allergists.
A real problem is how do small specialties expand. Training numbers are dictated by a formula, which depends on expected opportunities, calculated from the number of consultants and expected retirements, etc. This is controlled by the Specialist Advisory Working Group (SWAG) in the Department of Health. It is, therefore, difficult to increase the number of trainees, unless we can demonstrate consultant growth. The latter of course requires trainees. Trainees will also be reluctant to enter a speciality where prospects are poor. Pump-priming of a relatively small number of consultant allergist posts is needed.
Existing provision of allergy services in the UK
There are only six centres providing full-time allergy services run by a specialist allergist in the UK. All of these are in England mainly in the south and east: in Cambridge, Leicester, Southampton, and London (Guy's Hospital, Royal Brompton Hospital and St Mary's Hospital). There are also 15 clinics staffed by part-time specialist allergists.
There are no allergy posts in Scotland and Wales. A review of the service provision for Immunology and Allergy in Scotland for the Scottish Executive, identified 4 consultant immunologists and no allergists, and recommended an immediate increase in immunologists and a later increase in allergists 18 . The expertise of immunologists is different from that of allergists, and it is inappropriate for them to be asked to cover for allergy. A better solution would be to plan to appoint four allergists, to work alongside the immunologists.
In addition there are 81 'allergy clinics', where the service is provided by an organ-based specialist with an interest in allergy (data from BSACI Allergy Clinic Handbook 1998 i9 ). These vary, but the majority are not dedicated allergy clinics (allergy patients are seen within another speciality clinic, e.g. respiratory medicine or immunology). They operate from weekly to monthly, specialist services are lacking and commonly they were set up to deal with a restricted area of allergy (usually related to the consultant's own area, e.g. asthma for respiratory physicians or rhinitis for an ENT specialist). The reality, and a problem in terms of clinical governance, is that the nature of referrals is not restricted so that these clinics receive referrals they are ill-equipped to deal with, for example food allergy, drug allergy and anaphylaxis, much of which will be outwith the competence of the specialists running these clinics.
There are 27 consultant allergists in the UK (Manpower data 2000), so that there is only 1 consultant per 2.1 million population of UK.
Provision of allergy services in the future
Previous recommendations
The Royal College of Physicians Committee on Clinical Immunology and Allergy produced a report, The Physician Immunologist: Future Role and Manpower Needs in 1989 (20) . This was commissioned before the substantial rise in allergic disease, particularly severe allergic disease and anaphylaxis in the last decade. The model suggested was that most (about 80%) of allergic disease will be dealt with in primary care and that about 20% of patients should be referred to a specialist (allergist). It was proposed that the manpower provision should be one specialist allergist for three health districts, i.e. about 750,000 population.
Good Allergy Practice, a joint document of the Royal College of Physicians and Royal College of Pathologists in 1994, defined standards of care 21 . Requirements for a good allergy clinic were described, so that purchasers would better informed when contracting for allergy services.
Current model
An Allergy Task Force was set up in 1998, between the British Society of Allergy and Clinical Immunology and the Department of Health to discuss provision of allergy services in the NHS. The proposal is for 4 levels of provision of allergy care (Table 5 ).
There would be regional allergy centres, with a minimum of one per region, each with a minimum of two consultant allergists and appropriate support staff. These would provide specialist services for the Region, as Table 5 Provision of allergy care 1.
Regional allergy centres 2.
Allergists (in teaching hospitals and DGHs) 3.
Organ-based specialists with an interest 4.
Primary care
At present most care is provided by 3 and 4.
The balance should shift from 3 to 2 as new allergists are appointed.
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http://bmb.oxfordjournals.org/ Downloaded from well as services in all areas of allergy for their local population (a definition of specialist services is available to Regional Specialist Services Commissioning Groups). The regional centre would provide special diagnostic facilities (challenge tests, etc) and immunotherapy and act as an education and liaison resource for other doctors in the region. Throughout each region, general allergy services will also be provided in other teaching hospitals and district general hospitals, by allergists and by organ-based physicians with an interest in allergy. These allergists might have joint appointments in two hospitals, to provide geographical spread of expertise. In time, the balance should shift from organ-based specialists with an interest to trained allergists (with the Allergy CCST). The majority of allergic disease would be dealt with in primary care.
It should be noted that this model: (i) provides the minimum in specialist care; and (ii) assumes adequate expertise/knowledge of allergy at primary and secondary care levels. Unfortunately this does not exist at present.
